Cargando…
Systematic evaluation of irinotecan-induced intestinal mucositis based on metabolomics analysis
Chemotherapy-induced intestinal mucositis (CIM) is a major dose-limiting side effect of chemotherapy, especially in regimens containing irinotecan (CPT-11). Several studies on the pathologic mechanisms of CIM focused on both the genomics and molecular pathways triggered by chemotherapy. However, sys...
Autores principales: | Yu, Qing-Qing, Zhang, Heng, Zhao, Shiyuan, Xie, Dadi, Zhao, Haibo, Chen, Weidong, Pang, Min, Han, Baoqin, Jiang, Pei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520243/ https://www.ncbi.nlm.nih.gov/pubmed/36188576 http://dx.doi.org/10.3389/fphar.2022.958882 |
Ejemplares similares
-
The Intestinal Redox System and Its Significance in Chemotherapy-Induced Intestinal Mucositis
por: Yu, Qing-Qing, et al.
Publicado: (2022) -
Berberine Improves Irinotecan-Induced Intestinal Mucositis Without Impairing the Anti-colorectal Cancer Efficacy of Irinotecan by Inhibiting Bacterial β-glucuronidase
por: Yue, Bei, et al.
Publicado: (2021) -
Quantitative Evaluation of the Compatibility Effects of Huangqin Decoction on the Treatment of Irinotecan-Induced Gastrointestinal Toxicity Using Untargeted Metabolomics
por: Cui, Dong-Ni, et al.
Publicado: (2017) -
Dissecting Target Toxic Tissue and Tissue Specific Responses of Irinotecan in Rats Using Metabolomics Approach
por: Yao, Yiran, et al.
Publicado: (2017) -
Comprehensive evaluation of caloric restriction-induced changes in the metabolome profile of mice
por: Xie, Dadi, et al.
Publicado: (2022)